Home › a Recro buys pain medicine, manufacturing plant in a potential $170M deal
 

Keywords :   


a Recro buys pain medicine, manufacturing plant in a potential $170M deal

2015-03-09 15:38:08| Biotech - Topix.net

Recro Pharma Inc. signed a definitive agreement Monday to acquire the rights to an experimental pain medicine and a contract manufacturing facility from Alkermes in a deal valued at up to $170 million. Under the terms of the agreement, Recro Pharma of Malvern, Pa., will make an upfront payment of $50 million to Alkermes .

Tags: potential deal medicine manufacturing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
More »